Sonja Sattler, MD
CEO/Medical Director
Rosenpark Klinik, Darmstadt, Germany
Will We Need Aesthetic Surgery in the Future?
My minimally invasive aesthetic combination treatments to avoid future surgeries
SESSION 31 • Saturday, February 24, 2024 • 8:45am
Based on her dermatology background Sonja Sattler is working in Cosmetic/Aesthetic Medicine since 25 years. She is specialized in skin: facial rejuvenation with toxin, filler, EBDs including laser and its best combinations – as well as in general dermatologic surgery. She is also an expert in body rejuvenation including cellulite treatments and vaginal rejuvenation. Dr. Sonja Sattler has more than 20 publications in International Scientific Journals.
After graduation from Medical School in Human Medicine 1993 Dr. Sonja Sattler participated in a 5-year residency program on dermatology and dermatologic surgery. Together with her husband, Dr. Gerhard Sattler she founded 1996 Rosenpark Clinic, Rosenpark Research and BELLARI. Since that time, beside her work as an Aesthetic Physician and Researcher in Dermatology and Aesthetic Dermatology, she has been the guiding hand of the clinic in terms of finances, HR and organizational issues. Until 2018 she was organizing every other year the well-known “International Darmstadt Live Symposium for Dermatologic Surgery and Plastic Surgery” where experts gathered from around the world performing live surgeries. Since 2004 she is the Associate Executive Director of the International Society for Dermatologic Surgery (ISDS). Since many years she loves teaching, giving scientific lectures at national and international congresses, training courses and hands on trainings.
Lydia A. Bazzano, MD, PhD, MPH
Lynda B. and H. Leighton Stewart Professor of Nutrition
Director, Center for Lifespan Epidemiology Research
Tulane University School of Public Health and Tropical Medicine
The Future of Weight Loss:
The GLP-1 Agonist Revolution
SESSION 1 • Thursday, February 22, 2024 • 8:00am
Dr. Bazzano is the Lynda B and H. Leighton Steward Professor of Nutrition in the Department of Epidemiology at Tulane University’s School of Public Health and Tropical Medicine and Director of Tulane’s Center for Lifespan Epidemiology Research. She received a Bachelor of Science degree in biology from Newcomb College and earned her MPH, PhD, and MD from Tulane University. She completed her internship and residency at Beth Israel Deaconess Medical Center, Harvard Medical School, and is board certified in Internal Medicine. Dr. Bazzano’s research focus is the study of nutrition and its influence on chronic disease over the life course. She has led a number of NIH-funded research studies that explore dietary interventions for weight loss and the reduction of vascular risk factors, producing more than 200 peer-reviewed publications as first author or co-author. Dr. Bazzano served on the 2020-2025 Scientific Advisory Committee to the Dietary Guidelines for Americans. Her work on the macronutrient composition of weight loss diets has garnered attention from major media outlets including the New York Times, Time magazine, and National Public Radio.
Dr. Bazzano’s keynote address will explore the evolving landscape of weight loss interventions and examine promising advancements that will shape the future of obesity treatment. Discover how semaglutide and similar innovative treatments, originally developed for managing diabetes, are reshaping the landscape of aesthetic enhancements through weight loss stimulation, and learn the key management principles when considering these medications in your practice
Don’t miss this incredible opportunity to gain insights into this new frontier of cosmetic surgery.
J. Kevin Duplechain, MD, FAACS
Immediate Past President of AACS and CSF
Lafayette, Louisiana
2024 Webster Lecture
SESSION 17 • Friday, February 23, 2024 • 9:00am
Dr. Duplechain, a cosmetic surgeon, is board certified by the American Board of Cosmetic Surgery (ABCS), the American Board of Facial Cosmetic Surgery, the American Board of Facial Plastic Surgery, and the American Board of Otolaryngology/Head and Neck Surgery. Dr. Duplechain’s practice focuses on facial and body rejuvenation with a particular focus on facial rejuvenation. He has served on many committees including the emerging trends committee for the AAFPRS, the Young Surgeon’s Committee for the American College of Surgeons, and currently, oversees advocacy for the American Academy of Cosmetic Surgery. He has also served on the Executive Committee and the Board of Trustees for the American Board of Cosmetic Surgery. He helped revitalize and serve as the co-director of the AACS pre-conference Cadaver Workshop since 2015.
Dr. Duplechain, while serving on the executive committee for the ABCS, developed the “Campaign of 100” — the ABCS’s public awareness campaign — which has now raised over 1 million dollars on behalf of the ABCS. He has also served as the chairman for the American Society of Cosmetic Laser Surgery and has planned numerous meetings for the AACS including the World Congress of Liposuction in 2019, and the 2020 and 2021 AACS Annual Scientific Meetings. He has also been chosen as one of the Best Doctors in America by his peers for 25 consecutive years. Dr. Duplechain considers serving as the president of the AACS one of the greatest honors of his professional career.
Michelle Dresbold
Secrets Hidden in Your Handwriting:
Tips and Tools to Help Clinicians Make
More Informed Decisions
SESSION 15 • Friday, February 23, 2024 • 7:00am
Michelle Dresbold is an internationally-renowned Secret Service trained handwriting expert, personality profiler, author, speaker, and artist. For over twenty years, Michelle has drawn on her handwriting profiling skills to engage live and televised audiences, provide expert witness
services in hundreds of court cases, and fascinate readers of her syndicated columns and nationally published book, “Sex, Lies, and Handwriting.”
You will obtain insights on how to integrate Handwriting Analysis, also known as Brain Writing, into your practice to better understand your patients and staff and make more informed decisions, for example, with respect to hiring employees and potentially identifying diseases in patients such as depression, anorexia, or body image issues.